Insider Purchases: Inside the Buy

Tag: stock market 2026

Illustration of Zoetis as a premium veterinary titan sitting in a doghouse, with suited directors buying shares, institutional investors watching, pet-health products on shelves, and a chart showing 11x forward P/E after a major stock decline.

🐾 Zoetis (ZTS): A Premium Veterinary Titan Sitting in the Doghouse

Zoetis (ZTS) may be one of the most interesting “quality in the doghouse” setups of 2026. The global animal-health leader is still profitable, institutionally loved, and backed by powerful pet-humanization trends — yet soft U.S. pet spending, competition, and lowered guidance have crushed the stock. With directors buying near the lows and forward P/E near 11x, is ZTS finally becoming a value play?

Read entire article

Tags: animal diagnostics, animal health stocks, AnimalHealth, Biotech2026, buy or sell ZTS, companion animals, contrarian investing, director buying, dividend stocks, DividendStocks, falling knife stocks, featured-value, FUNanc1al, healthcare stocks, hub-insiders, hub-value, insider buying, InsiderBuying, livestock health, NYSE ZTS, pet health, pet humanization, risks buying ZTS, stock market 2026, StockMarketCrash, value investing, ValueInvesting, veterinary medicine, why buy ZTS, Zoetis, Zoetis stock analysis, ZTS, ZTS stock
Illustration of a worn sneaker representing Nike stock decline transitioning into a glowing running shoe symbolizing a potential turnaround, with a rising stock chart and investors buying at the bottom.

Nike (NKE) Stock: Insiders Keep Buying the Dip—Should You? 👟

Nike (NKE) has fallen sharply from its highs, but insider buying, strong brand equity, and improved valuation are turning heads. Is this the start of a comeback—or a trap?

Read entire article

Tags: buy or sell NKE, CEO Buy, consumer brands, dividend stocks, DividendGrowth, Elliott Hill, featured-insiders, FUNanc1al, FunStock, growth vs value, hub-insiders, insider buying, InsiderBuying, Nike stock, NikeStock, NKE, NKE analysis, retail stocks, risks buying NKE, share repurchase program, stock market 2026, StockMarket2026, TimCook, turnaround stocks, value investing, ValueInvesting, why buy NKE